Pregene Biotechnology Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $15.7M

  • Investors
  • 2

Pregene Biotechnology General Information

Description

Developer, producer and seller of molecular diagnostic kits and supporting instruments. The company develops ultra-multiplex PCR technology, droplet generation technology, advanced nucleic acid extraction technology and single-cell sequencing technology, enabling doctors to complete molecular diagnostics rapidly and cost-effectively.

Contact Information

Website
www.pregene.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Block C, Zhongdan Garden, No. 3-1
  • Xinjinhu Road, Pukou District
  • Nanjing, Jiangsu
  • China
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 3rd Floor, Block C, Zhongdan Garden, No. 3-1
  • Xinjinhu Road, Pukou District
  • Nanjing, Jiangsu
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pregene Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 10-Jan-2022 $15.7M Completed Generating Revenue
To view Pregene Biotechnology’s complete valuation and funding history, request access »

Pregene Biotechnology Patents

Pregene Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025015832-A1 High-throughput fluorescence detection method, apparatus and system, and storage medium Inactive 14-Jul-2023
WO-2024159661-A1 Polypeptide having dna polymerase activity and use thereof Inactive 01-Feb-2023
WO-2024065925-A1 Dna polymerase and preparation method therefor and use thereof Inactive 27-Sep-2022
US-20240318239-A1 Digital amplification detection method for simultaneously identifying multiple genotypes, detection product and detection kit Pending 09-Dec-2021
EP-4446433-A1 Digital amplification detection method, detection product and detection kit for simultaneously identifying multiple gene types Inactive 09-Dec-2021 C12Q1/6853
To view Pregene Biotechnology’s complete patent history, request access »

Pregene Biotechnology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Momentum Venture Venture Capital Minority
Vertex Ventures China Venture Capital Minority
To view Pregene Biotechnology’s complete investors history, request access »

Pregene Biotechnology FAQs

  • When was Pregene Biotechnology founded?

    Pregene Biotechnology was founded in 2019.

  • Where is Pregene Biotechnology headquartered?

    Pregene Biotechnology is headquartered in Nanjing, China.

  • What industry is Pregene Biotechnology in?

    Pregene Biotechnology’s primary industry is Diagnostic Equipment.

  • Is Pregene Biotechnology a private or public company?

    Pregene Biotechnology is a Private company.

  • What is Pregene Biotechnology’s current revenue?

    The current revenue for Pregene Biotechnology is .

  • How much funding has Pregene Biotechnology raised over time?

    Pregene Biotechnology has raised $15.7M.

  • Who are Pregene Biotechnology’s investors?

    Momentum Venture and Vertex Ventures China have invested in Pregene Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process